Sigal Charles Elliott 4
4 · Vir Biotechnology, Inc. · Filed Jun 3, 2024
Insider Transaction Report
Form 4
Sigal Charles Elliott
Director
Transactions
- Award
Common Stock
2024-05-30+8,000→ 23,806 total - Award
Stock Option (Right to Buy)
2024-05-30+16,000→ 16,000 totalExercise: $10.39From: 2025-05-30Exp: 2034-05-29→ Common Stock (16,000 underlying)
Holdings
- 10,000(indirect: By LLC)
Common Stock
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.